Geron
GERN
$3.98
Share price
1.35%
Change (1 day)
55.58%
Change (1 year)
Categories
Geron (GERN) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.14 B
According to Geron's latest financial reports the company's total liabilities are $0.14 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Geron - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.14 B | 32.15% |
| 2022-12-31 | $0.11 B | 11% |
| 2021-12-31 | $99.61 M | 66.64% |
| 2020-12-31 | $59.78 M | 96.89% |
| 2019-12-31 | $30.36 M | 302.09% |
| 2018-12-31 | $7.55 M | 15.88% |
| 2017-12-31 | $6.51 M | -17.19% |
| 2016-12-31 | $7.86 M | 18.62% |
| 2015-12-31 | $6.63 M | -84.13% |
| 2014-12-31 | $41.79 M | 450.93% |
| 2013-12-31 | $7.58 M | -46.37% |
| 2012-12-31 | $14.14 M | 5.24% |
| 2011-12-31 | $13.44 M | -67.09% |
| 2010-12-31 | $40.84 M | 423.37% |
| 2009-12-31 | $7.8 M | 0.54% |
| 2008-12-31 | $7.76 M | -41.29% |
| 2007-12-31 | $13.22 M | -71.8% |
| 2006-12-31 | $46.88 M | 83.52% |
| 2005-12-31 | $25.54 M | 160.4% |
| 2004-12-31 | $9.81 M | -16.8% |
| 2003-12-31 | $11.79 M | -61.88% |
| 2002-12-31 | $30.92 M | -10.84% |
| 2001-12-31 | $34.68 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | $39.37 B | 26,846.42% | 🇺🇸 USA |
 Incyte INCY | $1.59 B | 989.65% | 🇺🇸 USA |
 CTI BioPharma
CTIC | $0.13 B | -5.82% | 🇺🇸 USA |
 Bio-Techne TECH | $0.76 B | 425.02% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $46.89 M | -67.91% | 🇺🇸 USA |